Introduction
============

The disruption of homeostasis causes stress in response to damage to the body. However, sustained stress can lead to organ injury and diseases, including hypertension, diabetes, gastric ulcers and cancer. Gastric lesions are a typical organ injury associated with stress ([@b1-mmr-16-06-8673]). A water immersion restraint stress (WRS) model, which has been widely used in investigating stress-associated organ injury, imitates the clinical acute gastric lesions resulting from surgery, trauma and sepsis ([@b2-mmr-16-06-8673]). Elucidation of the mechanism underlying gastric injury induced by stress, and the development of specific therapeutic drugs are practically and clinically important. Physiological and psychological stress are involved in the pathogenesis of gastric ulceration. Anxiety, depression, helplessness and fear are considered to be the psychological responses ([@b3-mmr-16-06-8673]). Neurohormonal and immunological activation are incorporated in the physiological responses, and these two systems can interact under circumstances of stress ([@b4-mmr-16-06-8673],[@b5-mmr-16-06-8673]). However, the mechanisms underlying stress-induced acute gastric lesions remain to be elucidated.

The novel gastric dramatic downrelated gene (GDDR), which was also known as gastrokine 2, was first cloned using the Ends-Marathon Racein method, described in our previous study ([@b6-mmr-16-06-8673]). The expression of GDDR has been confirmed to be high in gastric mucosa epithelial cells in particular ([@b7-mmr-16-06-8673]), however, the expression of GDDR is significantly reduced in gastric cancer ([@b8-mmr-16-06-8673]). In the gastrointestinal tract, the secretion of GDDR is regulated by a series of cytokines, including interleukin (IL)-8 and IL-6, in addition to transforming growth factors (TGF)s ([@b9-mmr-16-06-8673]). The loss of GDDR drives premalignant gastric inflammation and tumor progression ([@b10-mmr-16-06-8673]). Poor prognosis and lymph node metastasis in gastric cancer have been closely linked to the loss of GDDR ([@b11-mmr-16-06-8673]). The expression of GDDR may suppress cancer cell proliferation through a TFF1-dependent manner, and induces apoptosis through the extrinsic apoptotic pathway ([@b12-mmr-16-06-8673],[@b13-mmr-16-06-8673]). Therefore, GDDR contributes to gastric mucosa homeostasis ([@b14-mmr-16-06-8673]) and acts as a putative tumor suppressor ([@b15-mmr-16-06-8673]). The function of GDDR remains to be fully elucidated unclear, however our previous study ([@b16-mmr-16-06-8673]) found that GDDR aggravated stress-induced gastric lesions, however, no significant differences were found between wild-type (WT) mice and GDDR-knockout (KO) mice without stress.

As it was previously shown that the expression of GDDR in gastric cancer significantly aggravated gastric lesions, based on biological functions and pathways analysis, the present study aimed to examine the process underlying gastric lesions at the molecular level, and provide insight for the identification of potential candidate biomarkers for drug targets, diagnosis and prognosis.

Materials and methods
=====================

### Formation of WRS-induced gastric mucosal lesions in mice

A total of 8 KO mice (male; age, 6--8 weeks; weight, \~20 g) were purchased from the Mutant Mouse Resource Research Center (Sacramento, CA, USA). The handling and care of the animals was implemented with reference to the National Institutes of Health guidelines. The temperature within the cages was controlled at 25±3°C, and the humidity was kept at 50±5%. Mice were given free access to water and food. The present study was performed following the approval of the Animal Experimentation Ethics Committee of Fudan University (Shanghai, China). The WRS model used in the present study has been widely used in investigations of gastric lesions ([@b17-mmr-16-06-8673]). The WRS model can mimic acute gastric lesions in humans to a high degree. GDDR shows stomach-restricted expression and is highly conserved among mammals ([@b18-mmr-16-06-8673]); therefore, GDDR shares similar functions among mammals. Prior to each experiment, the animals were starved for 24 h. The immersing of animals in water was performed to the extent of the xiphoid process in a restraint cage as previously described ([@b19-mmr-16-06-8673]). Following exposure to stress for the indicated duration (0 to 8 h), the animals were sacrificed. The stomachs of the animals were removed and immersed in RNAlater (Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 1 day. By cutting along the greater curvature, the stomachs were cut open and used for RNA extraction.

### RNA extraction and quality control

TRIzol^®^ reagent (Thermo Fisher Scientific, Inc.) was used to extract total RNA from each sample, according to the manufacturer\'s protocol. The concentrations of all samples were determined using a NanoDrop ND-2000 spectrophotometer (Thermo Fisher Scientific, Inc.). The Agilent Bioanalyzer 2100 (Agilent Technologies, Inc., Santa Clara, CA, USA) was used to evaluate the quality.

### Preparation of whole transcriptome libraries and deep sequencing

The Ion Total RNA-Seq kit v2 (Thermo Fisher Scientific, Inc.) was used to construct the sequencing library of the RNA samples in accordance with the manufacturer\'s protocol (Thermo Fisher Scientific, Inc.). In brief, Dynabeads mRNA purification (Thermo Fisher Scientific, Inc.) was utilized for refining poly(A)-containing mRNA. Fragmentation of the mRNA was implemented with the use of RNaseIII, following which the mRNA was purified. Subsequently, reverse transcription of the RNA fragments was performed by SuperScript™ II Reverse Transcriptase (Thermo Fisher Scientific, Inc.). The reverse transcribed mRNA was then amplified into double-stranded cDNA (42°C, 50 min; 70°C, 15 min), and was purified using a magnetic bead-based approach, following which concentrations of the samples were detected for the cDNA library. Sequencing quality was analyzed by RSeQC (version 2.6; <http://rseqc.sourceforge.net/>).

### Raw read filtering and mapping

The filtered raw reads ≥50 bp were used for the mapping. The TopHat (version 2.0.9; <http://ccb.jhu.edu/software/tophat/index.shtml>) tool was used for the RNA sequencing (RNA-seq) data mapping analysis based on spliced mapping, which is able to immediately and accurately identify the eukaryotic splicing ([@b20-mmr-16-06-8673]). EdgeR (version 3.5; <http://www.bioconductor.org/packages/release/bioc/html/edgeR.html>) was used to identified the differentially-expressed genes (DEGs).

### Gene Ontology (GO) and pathway enrichment analysis of DEGs

For the functional analysis of the DEGs, GO analysis was used to annotate genes and gene products, and to identify characteristic biological properties for high-throughput transcriptome or genome data ([@b21-mmr-16-06-8673]). Kyoto Encyclopedia of Genes and Genomes pathway (KEGG; <http://www.genome.jp/>) was used for systematic genetic functional analysis, to connect higher-order functional information with genomic information ([@b22-mmr-16-06-8673]). The genes were mapped to the relevant biological annotation in the Database for Annotation, Visualization and Integrated Discovery (DAVID; <https://david.ncifcrf.gov/>) to perform high-throughput gene functional analysis ([@b23-mmr-16-06-8673]). P\<0.05 was considered to indicate a statistically significant difference.

### Co-expression network

For each gene pair, the Pearson correlation coefficient was calculated and important correlation pairs were selected in order to establish the network ([@b24-mmr-16-06-8673]). The degree of centrality of a gene in the network was measured to determine the relative significance. By definition, the degree of centrality is the number of links of one node relative to another ([@b25-mmr-16-06-8673]).

### Integrative analysis of protein-protein interaction (PPI) networks and modules

The Search Tool for the Retrieval of Interactive Genes (STRING) database is an online tool for evaluating PPI information. The STRING database (version 10.0; <https://string-db.org/>) contains 9,600,000 types of protein in 2,000 organisms. For the assessment of interactions among DEGs in the present study, the DEGs were uploaded to the STRING database, and only interactions with a composite score \>0.4, which were experimentally validated, were considered to be significant. Cytoscape software (version 3.5.1; [www.cytoscape.org](www.cytoscape.org)) was then used to construct the PPI networks. Plug-in Molecular Complex Detection (MCODE) was then utilized for screening the PPI network modules in Cytoscape. The outcomes of the pathway and functional enrichment analysis were used for analyzing DEGs in the modules.

### Reverse-transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

The RT-qPCR assay was performed on the CFX96 Touch™ (Bio-Rad Laboratories, Inc., Hercules, CA, USA). According to the manufacturer\'s protocol, TRIzol^®^ reagent (Thermo Fisher Scientific, Inc.) was used to extract RNA from each sample. According to the manufacturer\'s protocol, cDNA synthesis was performed from 1 µg RNA with the use of a FastQuant RT kit (Tiangen Biotech Co., Ltd., Beijing, China). Subsequently, the PCR mixtures (25 µl) were prepared in triplicate, each containing 12.5 µl SYBR^®^ Premix Ex Taq (Takara Bio, Inc., Otsu, Japan), 1 µl of cDNA template, 0.5 µl primer (10 mM; Genewiz, Inc., Suzhou, China) and 3.6 ml DEPC-treated water. The primers included the following: Chemokine (C-X-C motif) ligand 2 (Cxcl2) forward, 5′-CCAACCACCAGGCTACAGG-3′ and reverse, 5′-GCGTCACACTCAAGCTCTG-3′; Tgf-β1 forward, 5′-CTCCCGTGGCTTCTAGTGC-3′ and reverse, 5′-GCCTTAGTTTGGACAGGATCTG-3′; IL-1β forward, 5′GCA ACT GTT CCT GAA CTC AAC T-3′ and reverse, 5′-ATCTTTTGGGGTCCGTCAACT-3′; insulin II (Ins2) forward, 5′-GCTTCTTCTACACACCCATGTC-3′ and reverse, 5′-AGCACTGATCTACAATGCCAC-3′; serine/threonine kinase 2 (Sgk2) forward, 5′-CCATTGGTTACCTTCACTCTCTC-3′ and reverse, 5′-GTCTCCTCAGGCTCTACACAT-3′; tuberous sclerosis 1 (Tsc1) forward, 5′-ACTCTCCCTTCTACCGAGACA-3′ and reverse, 5′-GAGGCTGCCGAATGAGTCTTC-3′; erb-B2 receptor tyrosine kinase 3 (Erbb3) forward, 5′-AAGTGACAGGCTATGTACTGGT-3′ and reverse, 5′-GCTGGAGTTGGTATTGTAGTTCA-3′; heparin-binding epidermal growth factor-like growth factor (Hbegf) forward, 5′-CGGGGAGTGCAGATACCTG-3′ and reverse, 5′-TTCTCCACTGGTAGAGTCAGC-3′; prostaglandin-endoperoxide synthase 2 (Ptgs2) forward, 5′-TTCAACACACTCTATCACTGGC-3′ and reverse, 5′-AGAAGCGTTTGCGGTACTCAT-3′; adhesion G protein-coupled receptor B1 (Adgrb1) forward, 5′-TTGCTCCACTCCTGCTGTTAC-3′ and reverse, 5′-GTAGCCGAAGAACTTTCCCTG-3′; glyceraldehyde 3-phosphate dehydrogenase (GAPDH) forward, 5′-TGGATTTGGACGCATTGGTC-3′ and reverse, 5′-TTTGCACTGGTACGTGTTGAT-3′. The conditions included initial denaturation at a temperature of 95°C for 30 sec, followed by 40 cycles (95°C, 5 sec; 60°C, 30 sec). Finally all quantified values were normalized to the endogenous GAPDH control. The 2^−∆∆Cq^ method was used to analyze gene expression levels ([@b26-mmr-16-06-8673]).

### Statistical analysis

The statistical analyses of data were performed using Student\'s t-test with SPSS software version 17.0 (SPSS, Inc., Chicago, IL, USA). Data are presented as the mean ± standard deviation. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Overview of sequencing data from RNA-seq analyses

The overall raw reads of the eight samples fell in the range of 46,000,000--82,000,000. Through strict quality checks, \>95% of the reads had a quality score of ≥Q20. The RSeQC package was used to analyze the sequencing quality ([@b27-mmr-16-06-8673]). The raw sequence data of each sample produced \~6 GB of data. Of the total raw reads, 96.5% (\~5.87±2.15×10^7^ reads) were mapped onto the mouse genome sequence in the eight separate samples ([Table I](#tI-mmr-16-06-8673){ref-type="table"}) and 89.1% of the total raw reads (5.42±1.92×10^7^ reads) were uniquely aligned to the mouse genome. The RNA-seq data was normalized to RPKM values for quantifying transcript expression levels.

### Selection of DEGs

The total samples analyzed in the present study comprised four WT stomach samples and four KO stomach samples. The data were analyzed individually with the use of edgeR and the lists of DEGs were identified. According to the results of the analyses, using the criteria of fold control \>2.0 and P\<0.05, a total of 1,704 genes were identified, of which 710 were downregulated and 994 were upregulated, respectively. The DEG gene expression heatmap is shown in [Fig. 1](#f1-mmr-16-06-8673){ref-type="fig"}, comprising the top 50 downregulated and upregulated genes. For targeting the DEGs, the DEGs were screened by GO terms, which were associated with phenotype ([Table II](#tII-mmr-16-06-8673){ref-type="table"}).

### GO term enrichment analysis

In order to identify the overrepresented categories (GO and KEGG pathways), all DEGs were uploaded to the online DAVID software. Based on the results of the GO analysis, there was significant enrichment of upregulated DEGs in biological processes (BP) encompassing muscle contraction, cell adhesion, and locomotion and response to wounding ([Table III](#tIII-mmr-16-06-8673){ref-type="table"}); there was significant enrichment of the downregulated DEGs in BPs encompassing regulation of nitrogen compound metabolic process, regulation of RNA metabolic process, and response to peptide hormone ([Table III](#tIII-mmr-16-06-8673){ref-type="table"}). For molecular function (MF), there was enrichment of the upregulated DEGs in transcription factor activity, cytoskeletal protein binding, sequence-specific binding by RNA polymerase II core promoter region, and calcium ion binding, and there was enrichment of the downregulated DEGs in serine-type peptidase activity, and serine-type endopeptidase activity, and serine hydrolase activity ([Table III](#tIII-mmr-16-06-8673){ref-type="table"}). In addition, based on the GO cell component (CC) analysis, there was significant enrichment of the upregulated DEGs in contractile fiber, myofibril, and contractile fiber part, and also significant enrichment of downregulated DEGs in extracellular space, zymogen granule and extracellular region part ([Table III](#tIII-mmr-16-06-8673){ref-type="table"}).

### KEGG pathway analysis

Based on the results of the KEGG pathway analysis, the most significantly enriched pathways of the downregulated DEGs and the upregulated DEGs were identified, as listed in [Table IV](#tIV-mmr-16-06-8673){ref-type="table"}. There was significant enrichment of the upregulated DEGs in the cGMP-PKG signaling pathway, focal adhesion, ECM-receptor interaction, PI3K-Akt signaling pathway and gastric acid secretion. There was enrichment of the downregulated DEGs in the endocrine, renin-angiotensin system, and other factor-regulated calcium reabsorption, PPAR signaling pathway, glycerolipid metabolism, and neuroactive ligand-receptor interaction.

### Gene co-expression network

Gene co-expression network analysis was performed between the highlighted groups of DEGs in synergy with possible involvement in BPs resulting in phenotypic changes. As shown in [Fig. 2A](#f2-mmr-16-06-8673){ref-type="fig"}, there was a positive correlation between the expression levels of insulin-like growth factor-binding protein 1 and plasminogen (Pearsons r=0.99), and these genes were involved in wound healing ([Fig. 2A](#f2-mmr-16-06-8673){ref-type="fig"}). In addition, a family of genes were associated with wound healing, including calponin 2, enolase 3, fibrinogen β chain, myogenic differentiation 1 and myosin heavy chain 2 (Myh2), in the WT mice ([Fig. 2A](#f2-mmr-16-06-8673){ref-type="fig"}). A group of genes associated with tight junction and focal adhesion, including actinin α2, actinin α3, myosin light chain, phosphorylatable, fast skeletal muscle and Myh2, were also correlated in the WT group. In the GDDR-/-group, it was found that 12 gene pairs of genes with similar expression profiles had involvement with proteolysis, which included CUB and zona pellucida-like domains 1/carboxypeptidase A2 (Cpa2), 2210010c04Rik/carboxypeptidase B1 (Cpb1), 2210010c04Rik/trypsin 5 (Try5), Cpa1/2210010c04Rik, Cpa2/protease, serine, 2 (Prss2), Cpb1/chymotrypsin-like elastase family member 1 (Cela1), Cela1/kallikrein 1 (Klk1), Cela2a/chymotrypsin-like (Ctrl), Try4/Cela3a, Ctrb1/Ctrl and Try4/Try5 ([Fig. 2B](#f2-mmr-16-06-8673){ref-type="fig"}).

### Module screening from the PPI network

According to the STRING database results, the screening of top hub nodes with high degrees higher linked to phenotype was implemented. These encompassed period circadian clock 3 (Per3), period circadian clock 2 (Per2), Ptgs2, period circadian clock 3 (Per1), cryptochrome circadian clock 1 (Cry1), α-actin-3 (Actg2), cardiac muscle 1 (Actc1), nitric oxide synthase 2 (Nos2), mitogen-activated protein kinase kinase kinase 1 (Map3k1), and growth arrest specific 7 (Gas7). In addition, 317 edges and 282 nodes were analyzed with the use of MCODE plug-ins. In this process, the top three significant modules were selected, and the functional genetic annotation of these modules was analyzed ([Fig. 3](#f3-mmr-16-06-8673){ref-type="fig"}). Based on the enrichment analysis, the genes in the top three modules were highly associated with negative regulation of the signaling pathway of glucocorticoid receptor, mesenchyme migration and response to organic substance ([Table V](#tV-mmr-16-06-8673){ref-type="table"}).

### Gene validation via RT-qPCR

The gene expression profiles of the DEGs were examined ([Table II](#tII-mmr-16-06-8673){ref-type="table"}). Based on the results of the RT-qPCR analysis, the gene expression profiles of the DEGs in the two groups of samples were consistent with the RNA-seq data, with the exception of Adgrb ([Fig. 4](#f4-mmr-16-06-8673){ref-type="fig"}). Of note, the expression level of Ptgs2 in the WT group was \~5-fold of that in the KO group. Adgrb1 in the KO mice was marginally higher than that in the WT mice (P\>0.05). Therefore, Adgrb1 may not contribute to the protection of the gastric mucosa under stress.

Discussion
==========

In the present study, the gene expression data of four WT mice and four KO mice were retrieved using the RNA-seq technique. In total, 1,704 DEGs were identified between the four KO samples and WT samples, of which 710 were downregulated and 994 were upregulated. The upregulated genes included Hbegf, Ptgs2, Cxcl2, Tgf-β1 and IL-1β. These genes are involved in the inflammatory response and immune response, and may aggravate gastric lesions. The downregulated genes included Ins2, Tsc1, Sgk2, Erbb3 and Map3k1. These genes are essential in proliferation, response to oxidative stress and negative regulation of acute inflammatory response. These genes can enhance the resistance of the gastric epithelia against damage and inhibit the acute inflammatory response. It has been reported that co-expressed genes are generally composed of a family of genes, which have similar expression profiles, and are frequently involved in parallel biological process. In the present study, a co-expression network was constructed among the DEGs from the WT mice and KO mice. The network may indicate how GDDR upregulates or downregulates DEGs, however, the results obtained in the present study were obtained from the whole stomach, containing various types of cells, therefore differences observed in the present study cannot be repeated in a single cell line. This indicates the merit of further investigation of the differences in one type of cell in the stomach. GO and KEGG pathway analyses were also performed to further elucidated the interactions of the DEGs. Based on the GO term analysis, the upregulated DEGs were predominantly associated with muscle contraction, cell adhesion, locomotion and response to wounding, whereas the downregulated DEGs were associated with regulation of nitrogen compound metabolic process, regulation of RNA metabolic process, and response to peptide hormone. These results are consistent with the knowledge that multiple processes, including increased nitrite/nitrate concentrations, the breakdown products of nitric oxide by inducible nitric oxide synthase in the gastric mucosa ([@b28-mmr-16-06-8673]), gene expression, response to peptide hormone ([@b3-mmr-16-06-8673]), microcirculation ([@b29-mmr-16-06-8673],[@b30-mmr-16-06-8673]) and the vasodilator effect ([@b31-mmr-16-06-8673]) are involved in acute gastric lesions. The KEGG pathways enriched in upregulated DEGs included focal adhesion, ECM-receptor interaction, PI3K-Akt signaling pathway, cGMP-PKG signaling pathway and gastric acid secretion ([@b32-mmr-16-06-8673]), The KEGG pathways enriched in the downregulated DEGs included the endocrine, renin-angiotensin system, other factor-regulated calcium reabsorption, glycerolipid metabolism, PPAR signaling pathway and neuroactive ligand-receptor interaction. The gastric lesion is the result of the disturbance between defensive and aggressive factors in the gastric mucosa ([@b30-mmr-16-06-8673]), including mucus secretion, mucosal blood flow and repair processes. Previous studies have shown that the renin-angiotensin system is important in gastric mucosal protection ([@b33-mmr-16-06-8673]). Evidence also indicates that the ECM-receptor interaction is involved during wound repair ([@b34-mmr-16-06-8673],[@b35-mmr-16-06-8673]). Activation in the PI3K-Akt signaling pathway has also been reported to be involved in protecting the gastric mucosal epithelium from damage ([@b36-mmr-16-06-8673]). Therefore, investigation of these signaling pathways may assist in predictions of gastric lesions and wound repair.

In the present study, a PPI network was also constructed with the DEGs, and the top degree hub genes were identified, which were involved in phenotype: Per3, Ptgs2, Per2, Cry1, Per1, Actg2, Actc1, Nos2, Map3k1 and Gas7. Ptgs2, also known as cyclooxygenase 2 (Cox-2), serves as the key enzyme in the process of prostaglandin biosynthesis, and is a peroxidase and dioxygenase. Ptgs2 is involved in the production of inflammatory prostaglandins, and the upregulation of Ptgs2 is involved in phenotypic changes, increased cell adhesion, resistance to apoptosis and tumor angiogenesis. Previous studies have reported that the expression of Cox-2 is induced in inflammatory cells at sites of inflammation ([@b37-mmr-16-06-8673]), and the presence of Cox-2 in the intact gastric mucosa is crucial for protection against injury caused by non-steroidal anti-inflammatory agents ([@b38-mmr-16-06-8673]). The second hub gene, Cry1, is a core component of the circadian clock, which regulates various physiological processes through gene expression according to circadian rhythms of \~24 h. It is an important regulator of a broad set of physiological functions, including immune and endocrine functions, which are involved in gastric lesions ([@b39-mmr-16-06-8673]--[@b41-mmr-16-06-8673]). The third hub gene, Per1, is a member of the period family of genes and functions in the repression of glucocorticoid receptor Nr3c1/Gr-induced transcriptional activity. It is important in gastric mucosal defense ([@b42-mmr-16-06-8673],[@b43-mmr-16-06-8673]) by reducing the association between Nr3c1/Gr and glucocorticoid response elements. In addition, Per1 is involved in modulating the inflammatory state via regulating the release of inflammatory mediators, including Ccl2 and IL6. Per2 is also a member of the period family, and is involved in maintaining cardiovascular functions through the regulation of NO and vasodilatatory prostaglandin production. Cry1 and Cry2 are transported into the nucleus by Per1 and Per2 proteins, with appropriate circadian timing. Cry1 and cry2 exhibit repressing activity, which has a direct effect on clock-controlled target genes by interacting with groups of RNA-binding proteins, helicases and other transcriptional repressors ([@b44-mmr-16-06-8673]). There is increasing evidence indicating that the functional disturbance of Nos2 can affect the response to hypoxia ([@b45-mmr-16-06-8673]) and innate immune response in the mucosa ([@b46-mmr-16-06-8673]). It can release NO, serving as a messenger molecule with distinct biological functions in the body. Map3k1 encodes a serine/threonine kinase and is known to be involved in certain signal-transduction cascades encompassing the c-Jun N-terminal kinase and extracellular signal-regulated kinase kinase pathways, and the nuclear factor-kB pathway. Reactive oxygen species are signaling molecules, which function in stimulating the protein synthesis of hypoxia-inducible factor 1 α (Hif-1α) through activating the mitogen-activated protein kinase (MAPK) pathways ([@b47-mmr-16-06-8673]). To date, the biological functions of MAPK in acute gastric lesion remains to be elucidated.

Based on module analysis of the PPI networks, the process of gastric lesions in WT mice were associated with regulation of the glucocorticoid receptor signaling pathway, regulation of the cellular stress response to stress, and regulation of hormone secretion. It has been established that acutely increased corticosterone has a protective effect on the stomach against injury induced by stress ([@b48-mmr-16-06-8673]). It has also been demonstrated that the gastroprotective activity of glucocorticoids results from the maintenance of mucus secretion, repair processes and gastric mucosal blood flow, and the attenuation of harmful factors, including increasing microvascular permeability and gastric motility ([@b47-mmr-16-06-8673],[@b49-mmr-16-06-8673]). In addition, glucocorticoids have a compensatory gastroprotective role if the gastro-protective mechanisms rendered by NO, capsaicin-sensitive sensory neurons and prostaglandins are impaired ([@b48-mmr-16-06-8673]).

The present study focused on the differences caused by GDDR under stress-induced conditions. The WT and KOmice groups were used to compare and analyze the differences. The correlation between the expression of DEGs and the degree of pathologic damage was not examined in the present study and requires further investigation. The present study focused on examining the differences between WT mice and GDDR-/- mice associated with phenotype. The DEGs analyzed in the present study were also based on phenotype. As, in the absence of stress, no significant differences are found between the WT mice and KO mice, the gene expression profiles in WT mice with and without stress were not examined in the present study.

In conclusion, comprehensive bioinformatics analysis of the DEGs was performed in the present study, which may be associated with acute gastric lesions and regulated by GDDR. The results provided an array of potent targets for future investigations of the molecular mechanisms. The functions of the genes identified in gastric lesions require confirmation in further molecular biological experiments.

This study was supported by the National Natural Science Foundation of China (grant no. 81270440).

![Heat map of the top 100 differentially-expressed genes. The heat map shows the 50 upregulated genes and 50 downregulated genes. Red indicates upregulation; green indicates downregulation. WT, wild-type; KO, knockout.](MMR-16-06-8673-g00){#f1-mmr-16-06-8673}

![Gene co-expression network analysis. (A) Wild-type mice; (B) Knockout mice. Pearson\'s correlation coefficients of each pair of genes were calculated from these four independent samples in each group. Co-expressed genes are indicated by connecting lines.](MMR-16-06-8673-g01){#f2-mmr-16-06-8673}

![Top three modules from the protein-protein interaction network. (A) module 1, (B) module 2, (C) module 3. Proteins that interact directly are indicated by connecting lines.](MMR-16-06-8673-g02){#f3-mmr-16-06-8673}

![Reverse transcription-quantitative polymerase chain reaction analysis for validation of relative expression levels of representative differentially-expressed genes. (A) Upregulated genes in WT mice; (B) upregulated genes in knockout mice. \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001, \*\*\*\*P\<0.0001. WT, wild-type; GDDR, gastric dramatic downrelated gene; Hbegf, heparin binding EGF-like growth factor; Ptgs2, prostaglandin-endoperoxide synthase 2; Ins2, insulin II; Tsc1, tuberous sclerosis 1; Cxcl2, C-X-Cmotif chemokine ligand 2; Tgf-β, transforming growth factor-β; Sgk2, serine/threonine kinase 2; IL-1β, interleukin; Adgrb, adhesion G protein-coupled receptor B1.](MMR-16-06-8673-g03){#f4-mmr-16-06-8673}

###### 

Statistical results of raw and mapped reads from RNA sequencing analysis of the two sample groups.

  Sample ID   All reads (n)   Mapped reads (n)   Mapped pair reads (n)   Mapped unique reads (n)   Mapped multi reads (n)   Mapping ratio (%)
  ----------- --------------- ------------------ ----------------------- ------------------------- ------------------------ -------------------
  WT1         61,240,034      59,117,022         56,525,230              55,294,584                3,822,438                96.53
  WT2         46,121,381      44,464,612         42,679,266              41,326,294                3,138,318                96.41
  WT3         54,133,981      52,125,800         49,324,700              49,085,506                3,040,294                96.29
  WT4         54,339,065      52,141,402         49,743,718              48,844,972                3,296,430                95.96
  KO1         72,474,184      70,219,525         65,940,540              63,560,829                6,658,696                96.89
  KO2         82,629,329      80,169,680         75,009,586              73,414,418                6,755,262                97.02
  KO3         56,526,935      54,505,009         52,003,246              50,639,935                3,865,074                96.42
  KO4         58,853,154      56,795,811         54,334,810              51,286,425                5,509,386                96.50

WT, wild-type mouse; KO, gastric dramatic downrelated gene-knockout mouse.

###### 

Differentially-expressed genes associated with functions and phenotypes.

  Gene symbol     Description                              Log2FC   P-value        Gene ontology term
  --------------- ---------------------------------------- -------- -------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Upregulated                                                                      
  Hbegf           Heparin binding EGF-like growth factor   −2.86    3.79×10^−34^   Angiogenesis; extracellular space; epidermal growth factor receptor signaling pathway; growth factor activity
  Ptgs2           Prostaglandin-endoperoxide synthase 2    −1.88    2.83×10^−09^   Negative regulation of toll-like receptor signaling pathway; prostaglandin biosynthetic process;
  Cxcl2           C-X-C motif chemokine ligand 2           −3.97    3.80×10^−07^   Cytokine activity; extracellular region; inflammatory response; G-protein coupled receptor signaling pathway; neutrophil chemotaxis
  Tgf-β1          Transforming growth factor-β1            −1.48    1.55×10^−06^   Transcription coactivator activity; focal adhesion; positive regulation of epithelial to mesenchymal transition; Wnt signaling pathway
  IL-1β           Interleukin-1β                           −2.58    2.28×10^−04^   Activation of MAPK activity; positive regulation of protein phosphorylation cytokine activity
  Downregulated                                                                    
  Ins2            Insulin II                               5.01     7.42×10^−11^   Negative regulation of transcription from RNA polymerase II promoter; MAPK cascade; negative regulation of acute inflammatory response; extracellular region
  Tsc1            Tuberous sclerosis 1                     1.31     4.44×10^−09^   Regulation of cell-matrix adhesion; adaptive immune response; protein binding; cytoplasm
  Sgk2            Serine/threonine kinase 2                1.22     1.06×10^−08^   Nucleotide binding; regulation of cell growth; protein serine/threonine kinase activity; cytoplasm
  Erbb3           Erb-B2 receptor tyrosine kinase 3        1.07     3.75×10^−07^   Nucleotide binding; protein kinase activity; transmembrane receptor protein tyrosine kinase activity; receptor signaling protein tyrosine kinase activity; protein binding
  Adgrb1          Adhesion G protein-coupled receptor B1   1.17     1.24×10^−06^   Transmembrane signaling receptor activity; G-protein coupled receptor activity; protein binding; plasma membrane

FC, fold change; MAPK, mitogen-activated protein kinase.

###### 

GO analysis of differentially-expressed genes associated with gastric lesions.

  Expression      Category   Term/gene function                                                                                           Gene count   \%      P-value
  --------------- ---------- ------------------------------------------------------------------------------------------------------------ ------------ ------- -------------
  Upregulated     BP         GO:0006936-muscle contraction                                                                                  69           7.2   3.1×10^−32^
                  BP         GO:0007155-cell adhesion                                                                                     144          14.9    1.9×10^−16^
                  BP         GO:0040011-locomotion                                                                                        138          14.3    1.5×10^−15^
                  BP         GO:0009611-response to wounding                                                                                69           7.2   3.7×10^−15^
                  BP         GO:0030198-extracellular matrix organization                                                                   42           4.4   1.5×10^−14^
                  CC         GO:0043292-contractile fiber                                                                                   72           7.5   1.7×10^−36^
                  CC         GO:0030016-myofibril                                                                                           70           7.3   5.3×10^−36^
                  CC         GO:0044449-contractile fiber part                                                                              67           7.0   1.1×10^−34^
                  CC         GO:0030017-sarcomere                                                                                           65           6.7   2.3×10^−34^
                  CC         GO:0005578-proteinaceous extracellular matrix                                                                  78           8.1   2.5×10^−27^
                  MF         GO:0008092-cytoskeletal protein binding                                                                        87           9.0   1.9×10^−12^
                  MF         GO:0000982-transcription factor activity, RNA polymerase II core promoter region sequence-specific binding     53           5.5   6.1×10^−12^
                  MF         GO:0005509-calcium ion binding                                                                                 76           7.9   6.9×10^−12^
                  MF         GO:0000981-RNA polymerase II transcription factor activity, sequence-specific DNA binding                      74           7.7   1.6×10^−11^
                  MF         GO:0003779-actin binding                                                                                       50           5.2   1.0×10^−10^
  Downregulated   BP         GO:0051252-regulation of RNA metabolic process                                                               105          18.5    3.1×10^−06^
                  BP         GO:0051171-regulation of nitrogen compound metabolic process                                                 115          20.3    2.9×10^−05^
                  BP         GO:0010468-regulation of gene expression                                                                     115          20.3    4.8×10^−05^
                  BP         GO:0044242-cellular lipid catabolic process                                                                    12           2.5   8.5×10^−04^
                  BP         GO:0043434-response to peptide hormone                                                                         17           2.6   1.5×10^−02^
                  CC         GO:0005615-extracellular space                                                                                 62         10.9    1.5×10^−08^
                  CC         GO:0042588-zymogen granule                                                                                       5          0.9   1.0×10^−03^
                  CC         GO:0044421-extracellular region part                                                                           96         16.9    1.2×10^−03^
                  CC         GO:0005576-extracellular region                                                                              107          18.9    1.3×10^−03^
                  CC         GO:0005576-zymogen granule membrane                                                                              4          0.7   2.3×10^−03^
                  MF         GO:0004252-serine-type endopeptidase activity                                                                  29           5.1   1.6×10^−15^
                  MF         GO:0008236-serine-type peptidase activity                                                                      29           5.1   2.2×10^−14^
                  MF         GO:0017171-serine hydrolase activity                                                                           29           5.1   3.0×10^−14^
                  MF         GO:0043169-cation binding                                                                                    139          24.5    4.4×10^−12^
                  MF         GO:0046872-metal ion binding                                                                                 138          24.5    4.6×10^−12^

GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function.

###### 

Kyoto Encyclopedia of Genes and Genomes pathway analysis of differentially-expressed genes associated with gastric lesions

  Pathway ID      Name                                                        Gene count   \%      P-value       Genes
  --------------- ----------------------------------------------------------- ------------ ------- ------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Upregulated                                                                                                    
  mmu04512        ECM-receptor interaction                                    22             2.3   1.6×10^−10^   Col1a1, Col1a2, Col3a1, Col4a, Col4a2, Col4a, Col4a6, Col5a1, Col5a2, Col5a3, Col6a1, Col6a, Col6a3, Fn1, Itga11, Itga3, Lamb2, Npnt, Hspg2, Tnxb, Thbs1, Thbs4
  mmu04510        Focal adhesion                                              32             3.3   2.1×10^−09^   Shc2, Actn2, Actn3, Col1a1, Col1a2, Col3a1, Col4a1, Col4a2, Col4a5, Col4a6, Col5a1, Col5a2, Col5a, Col6a1, Col6a2, Col6a3, Fn1, Flnc, Itga11, Itga3, Jun, Lamb2, Mylk3, Mylk4, Mylpf, Mylk2, Mylk, Tnxb, Thbs1, Thbs4, Vegfc, Zyx
  mmu04022        Cgmp-PKG signaling pathway                                  23             2.5   6.7×10^−06^   Atp2a1, Atp1a2, Atp1b2, Atf6b, Adcy1, Adcy3, Adcy7, Adra1a, Cacna1s, Gucy1b3, Irs2, MEF2C, Mylk3, Mylk4, Mylk2, Mylk, Nfatc4, Pde5a, Pln, Kcnmb1, Srf, Slc8a2, Tprc6
  mmu05146        PI3K-Akt signaling pathway                                  34             3.5   3.7×10^−05^   Epha2, Atf6b, Chrm2, Col1a1, Col1a2, Col3a1, Col4a1, Col4a2, Col4a5, Col4a6, Col5a1, Col5a2, Col5a3, Col6a1, Col6a2, Col6a3, Efna3, Fgf10, Fgf11, Fgf1, Fn1, Gnb4, Itga11, Itga3Lamb2, Ngfr, Ngf, Osm, Nr4a, Ppp2r5b, Tnxb, Thbs1, Thbs4, Vegfc
  mmu05414        Gastric acid secretion                                      12             1.2   3.2×10^−04^   Atp1a2, Atp1b2, Adcy1, Adcy3, Adcy7, Camk2a, Gast, Mylk3, Mylk4, Mylk2, Myl, Kcne2
  Downregulated                                                                                                  
  mmu04614        Renin-angiotensin system                                      8            1.4   1.7×10^−06^   Mas1, Klk1, Klk1b11, Klk1b24, Klk1b, Klk1b5, Klk1b8, Klk1b26
  mmu04961        Endocrine and other factor-regulated calcium reabsorption     7            1.2   2.5×10^−04^   Klk1, Klk1b11, Klk1b24, Klk1b3, Klk1b5, Klk1b8, Klk1b26
  mmu00561        Glycerolipid metabolism                                       6            1.3   2.9×10^−03^   Cel, Lpin1, Lpin2, Phliprp1, Pnli, Pnliprp2
  mmu03320        PPAR signaling pathway                                        5            1.0   4.7×10^−02^   Acox2, Angptl4, Cpt1a, Cyp4a32, Ehhdh
  mmu04080        Neuroactive ligand-receptor interaction                     10             2.1   5.3×10^−02^   Gpr156, Mas, 1810009j06Rik, 2210010c04Rik, Oprd1, Try5, Gm10334, Prss2, Sctr, Try4

###### 

Pathways enriched in modules of the protein-protein interaction network.

  Gene set                                                           P-value        FDR            Nodes
  ------------------------------------------------------------------ -------------- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Module 1                                                                                         
  Negative regulation of glucocorticoid receptor signaling pathway   1.79×10^−07^   9.81×10^−07^   Per1, Cry1, Arntl
  Regulation of hormone secretion                                    4.21×10^−03^   2.01×10^−04^   Per2, Nr1d1, Cry1, Arntl
  Regulation of cellular response to stress                          3.48×10^−03^   7.03×10^−03^   Sfpq, Per1, Cry1, Arntl
  Module 2                                                                                         
  Mesenchyme migration                                               1.23×10^−08^   1.30×10^−09^   Acta1, Actc1, Acta2, Actg2
  Mesenchyme morphogenesis                                           5.54×10^−05^   6.76×10^−06^   Acta1, Actc1, Acta2, Actg2
  Cytoskeleton organization                                          4.26×10^−04^   4.64×10^−04^   Gas7, Cap2, Cnn2, Fscn1, Myh10, Acta1
  Module 3                                                                                         
  Response to organic substance                                      1.34×10^−02^   4.48×10^−10^   Zyx, Pygm, Slc11a2, Nos2, Ptgs2, Slc7a11, Ampd1, Epha2, Zx3h12a, Hspa1a, Hsph1, Afp, Myod1, Map3k1, Jun, Dusp1, Cpt1a, Dusp10, Tsc1, Fosb, Fos1, Junb, Atf3, Ddit3, HmgcS2, Hipk2, Oprd1, E2f1, Bysl, Cad, Dpysl2, Abcc2, Fasn, Sel1l, Klf2, Trib1, Abcc2, Atp1a2, Melf2c
  Response to lipid                                                  5.13×10^−03^   2.73×10^−09^   Fosb, Fosl1, Fos, Jun, Nos2, Ptgs2, Dusp1, Junb, Dusp10, Hmgcc2, Jund, Cebpa, Nr4a2, Trib1, Myod1, Sox9, Atp1a2, E2f1, Bysl, Cad, Mef2c, Zc3h12a, Abcc2, Cpt1a
  Regulation of cell death                                           8.13×10^−03^   5.26×10^−08^   Nr4a2, Fosl1, Ptgs2, Slc11a2, Map3k1, Birc3, Junb, Jund, Atf3, Ddit3, Hspb1, Gadd45a, Erbb3, Bag3, Hsph1, Plk, Plk2, Sfn, Sox, Hipk2, Mef2, Vdr, Pdc, Igf1r, Rhob, Spry2, Steap3, Siah2, Ngfr

FDR, false discovery rate.
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